Recent Updates
Recently added Catalysts
GILD Positive Sentiment Score: 75/100

Gilead Sciences to Present at Upcoming Second Quarter 2026 Investor Conferences

Key Takeaway: Gilead Sciences, Inc. announced its participation in several upcoming investor conferences, including the BofA Securities Health Care Conference and the RBC Capital Markets Global Healthcare Conference. Executives will present on various dates in May and June 2026. Live webcasts of the presentations will be available on the company's investor page.

Market Sentiment Analysis

POSITIVE FACTORS

  • Gilead Sciences is actively engaging with investors.
  • The company has a history of breakthroughs in medicine.
  • Presentations at multiple conferences indicate strong communication strategy.

Full Press Release Details

FOSTER CITY, Calif.--(BUSINESS WIRE)--Gilead Sciences, Inc. (Nasdaq: GILD) announced today that its executives will be speaking at the following investor conferences:
• BofA Securities Health Care Conference on Tuesday, May 12 at 2:20 PM Pacific Time
• RBC Capital Markets Global Healthcare Conference on Tuesday, May 19 at 11:00 AM Eastern Time
• Bernstein Annual Strategic Decisions Conference on Thursday, May 28 at 11:00 AM Eastern Time
• Goldman Sachs Annual Global Healthcare Conference on Tuesday, June 9 at 1:20 PM Eastern Time
The live webcasts can be accessed at the company’s investors page atinvestors.gilead.com. The replays will be available for at least 30 days following the presentation.

About Gilead Sciences

Gilead Sciences, Inc. is a biopharmaceutical company that has pursued and achieved breakthroughs in medicine for more than three decades, with the goal of creating a healthier world for all people. The company is committed to advancing innovative medicines to prevent and treat life-threatening diseases, including HIV, viral hepatitis, COVID-19, and cancer. Gilead operates in more than 35 countries worldwide, with headquarters in Foster City, California.
For more information on Gilead Sciences, please visit the company’s website atwww.gilead.com, follow Gilead on Twitter (@GileadSciences) or call Gilead Public Affairs at 1-800-GILEAD-5 or 1-650-574-3000.

Frequently Asked Questions

When is Gilead Sciences presenting at investor conferences?

Gilead Sciences will present at several conferences from May 12 to June 9, 2026.

How can I access Gilead's conference presentations?

Live webcasts of Gilead's presentations can be accessed on their investor page.

What is the focus of Gilead Sciences?

Gilead focuses on developing innovative medicines for life-threatening diseases.

Where is Gilead Sciences headquartered?

Gilead Sciences is headquartered in Foster City, California.

Last updated: May 1, 2026